FDA-Drug2017-02-22Class II
Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cincinnati OH 45237 USA, NDC 0591-0900-30, UPC 3-0591090030-4
Actavis Inc
Hazard
Failed Dissolution Specifications. Above out of specification for dissolution rate observed at the 10 hour testing point.
Sold states
Nationwide in US
Affected count
499320 units
Manufactured in
400 Interpace Pkwy, N/A, Parsippany, NJ, United States
Products
Glipizide extended-release tablets, 2.5mg, 30-count bottle, Rx Only, Manufactured By Patheon Pharmaceuticals Inc Cincinnati OH 45237 USA, NDC 0591-0900-30, UPC 3-0591090030-4
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0476-2017Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief